Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive multi-dose tranexamic acid in elderly hip fracture arthroplasty
ChiCTR2100054791Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in hip fracture (2 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoints: Hidden blood loss, Decline of hemoglobin level and 1 more. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
hip fracture
Beyond the preview
Go deeper on ChiCTR2100054791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054791.